JP2024537170A5 - - Google Patents
Info
- Publication number
- JP2024537170A5 JP2024537170A5 JP2024520862A JP2024520862A JP2024537170A5 JP 2024537170 A5 JP2024537170 A5 JP 2024537170A5 JP 2024520862 A JP2024520862 A JP 2024520862A JP 2024520862 A JP2024520862 A JP 2024520862A JP 2024537170 A5 JP2024537170 A5 JP 2024537170A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163252850P | 2021-10-06 | 2021-10-06 | |
| US63/252,850 | 2021-10-06 | ||
| PCT/US2022/077610 WO2023060126A1 (en) | 2021-10-06 | 2022-10-05 | Engineered cytokine receptors for tunable adoptive cell therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537170A JP2024537170A (ja) | 2024-10-10 |
| JP2024537170A5 true JP2024537170A5 (https=) | 2025-10-15 |
Family
ID=85803736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520862A Pending JP2024537170A (ja) | 2021-10-06 | 2022-10-05 | 調整可能な養子細胞療法のための操作されたサイトカイン受容体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240408139A1 (https=) |
| EP (1) | EP4413029A4 (https=) |
| JP (1) | JP2024537170A (https=) |
| AU (1) | AU2022361486A1 (https=) |
| CA (1) | CA3233987A1 (https=) |
| WO (1) | WO2023060126A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024123835A1 (en) * | 2022-12-06 | 2024-06-13 | Dynamic Cell Therapies, Inc. | Engineered switches for immune cell activity and methods of use thereof |
| WO2024123836A1 (en) * | 2022-12-06 | 2024-06-13 | Dynamic Cell Therapies, Inc. | Immune-activating complexes |
| WO2025039159A1 (en) * | 2023-08-21 | 2025-02-27 | Hangzhou Hervor Therapeutics Co., Ltd | Synthetic cytokine signaling system, preparation method, and uses thereof |
| WO2025255267A1 (en) * | 2024-06-05 | 2025-12-11 | Dynamic Cell Therapies, Inc. | Engineered receptors for activation of regulatory t-cells |
| WO2026082710A1 (en) * | 2024-10-16 | 2026-04-23 | F. Hoffmann-La Roche Ag | Small molecule-inducible recombinant receptors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151665A2 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| CN108064176A (zh) * | 2015-04-22 | 2018-05-22 | 库瑞瓦格股份公司 | 用于治疗肿瘤疾病的含有rna的组合物 |
| GB201507368D0 (en) * | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| EP3786293A1 (en) * | 2015-06-12 | 2021-03-03 | AxioMx, Inc. | Methods and compositions for producing a chimeric polypeptide |
| WO2019236522A1 (en) * | 2018-06-04 | 2019-12-12 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for targeted immunotherapy |
| AU2019346335B2 (en) * | 2018-09-28 | 2024-07-25 | Massachusetts Institute Of Technology | Collagen-localized immunomodulatory molecules and methods thereof |
| US20200147137A1 (en) * | 2018-11-08 | 2020-05-14 | WUGEN, Inc. | Compositions and methods for treatment of cancer |
| WO2020191305A2 (en) * | 2019-03-20 | 2020-09-24 | Massachusetts Institute Of Technology | Uses of amphiphiles in immune cell therapy and compositions therefor |
-
2022
- 2022-10-05 US US18/699,108 patent/US20240408139A1/en active Pending
- 2022-10-05 AU AU2022361486A patent/AU2022361486A1/en active Pending
- 2022-10-05 WO PCT/US2022/077610 patent/WO2023060126A1/en not_active Ceased
- 2022-10-05 CA CA3233987A patent/CA3233987A1/en active Pending
- 2022-10-05 JP JP2024520862A patent/JP2024537170A/ja active Pending
- 2022-10-05 EP EP22879450.9A patent/EP4413029A4/en active Pending